1. Home
  2. LIXT vs UONEK Comparison

LIXT vs UONEK Comparison

Compare LIXT & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$5.35

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Logo Urban One Inc. Class D

UONEK

Urban One Inc. Class D

N/A

Current Price

$5.06

Market Cap

26.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
LIXT
UONEK
Founded
2005
1980
Country
United States
United States
Employees
3
1272
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
26.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIXT
UONEK
Price
$5.35
$5.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
63.5K
16.8K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.45
52 Week High
$6.09
$9.38

Technical Indicators

Market Signals
Indicator
LIXT
UONEK
Relative Strength Index (RSI) 67.95 43.09
Support Level $3.77 $4.75
Resistance Level $6.03 $6.12
Average True Range (ATR) 0.63 0.64
MACD 0.05 -0.02
Stochastic Oscillator 82.72 17.14

Price Performance

Historical Comparison
LIXT
UONEK

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: